Published in Oncol Lett on August 30, 2016
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med (2013) 14.78
SOX2 functions to maintain neural progenitor identity. Neuron (2003) 7.48
DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med (2008) 5.87
Lung cancer. Lancet (2000) 3.93
Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med (2011) 3.74
Multiple roles for Sox2 in the developing and adult mouse trachea. Development (2009) 2.62
Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol (2008) 2.06
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer (2011) 1.74
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol (2011) 1.66
Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol (2010) 1.53
SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol (2011) 1.40
SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer (2011) 1.14
High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One (2013) 1.13
Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. J Transl Med (2010) 1.02
SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum Pathol (2009) 1.00
Increased Sox2 copy number in lung squamous cell carcinomas. Exp Ther Med (2011) 0.90